Blepharophimosis, ptosis, epicanthus inversus syndrome

Last updated
Blepharophimosis, ptosis, epicanthus inversus syndrome
Other namesBlepharophimosis types 1 and 2
Blepharophimosis.png
18-year-old female with BPES type 1
This condition is inherited in an autosomal dominant manner. Autosomal dominant - en.svg
This condition is inherited in an autosomal dominant manner.

Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare medical anomaly characterized by the conditions it is named after: blepharophimosis, ptosis and epicanthus inversus. There are two types; type 1 is distinguished from type 2 by including the symptom of premature ovarian insufficiency (POI) in females, which causes menopausal symptoms and infertility in patients as young as 15 years old. [1]

Contents

Signs and symptoms

The most prominent symptoms of BPES are horizontally narrow eyes (blepharophimosis), drooping eyelids (ptosis) and a fold of skin running from the side of the nose to the lower eyelid (epicanthus inversus). Other common symptoms include lack of an eyelid fold, an appearance of widely spaced eyes (telecanthus), low nose bridge and ear malformations (including cupping and incomplete development). Rare symptoms include microphthalmos (abnormally small eyes), tear ducts in the wrong location and a high-arched palate. [1] Type 1 BPES is distinguished by including premature ovarian insufficiency (POI) in females, which causes menopausal symptoms and infertility in patients as young as 15 years old. [1] Type 2 is identified by the development of an abnormal eyelid and no infertility in either men or women. [2]

Genetics

BPES is caused by a mutation in the gene FOXL2 , located at 3q23 (band 23 on the long arm of chromosome 3). There are two types, caused by different mutations in this gene, but both follow an autosomal dominant pattern of inheritance. [1]

Diagnosis

Though BPES can be suggested by the presence of blepharophimosis, ptosis and/or epicanthus inversus, it can only be definitively diagnosed by genetic testing. A small percentage of patients tend to have a systematic disorder in addition to blepharophimosis. [3] Other disorders that appear similar include Waardenburg syndrome and Ohdo blepharophimosis syndrome. [1]

Treatment

The main treatment is symptomatic, since the underlying genetic defect cannot be corrected as of 2015. Symptomatic treatment is surgical. [1]

Epidemiology

BPES is rare as it only appears in 1 in 50,000 individuals. [4] It affects slightly more males than females. [1]

References

  1. 1 2 3 4 5 6 7 "Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2015-10-30.
  2. ↑ De Baere, Elfride; Beysen, Diane; Oley, Christine; Lorenz, Birgit; Cocquet, Julie; De Sutter, Paul; Devriendt, Koen; Dixon, Michael; Fellous, Marc; Fryns, Jean-Pierre; Garza, Arturo; Jonsrud, Christoffer; Krause, Amanda (2003). "FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation". American Journal of Human Genetics. 72 (2): 478–487. doi:10.1086/346118. PMC   379240 . PMID   12529855.
  3. ↑ Landau Prat, Daphna; Nguyen, Brian; Strong, Alanna; Katowitz, William; Katowitz, James (July 2021). ""Blepharophimosis-plus" syndromes: Frequency of systemic genetic disorders that also include blepharophimosis". Clinical & Experimental Ophthalmology. 49 (5): 448–453. doi:10.1111/ceo.13933 – via EBSCO.
  4. ↑ Zhao, Mingyu; Meng, Xiaolu; Wang, Jiaqi; Wang, Tailing (February 2024). "Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome". Frontiers in Genetics. 15 1343411. doi: 10.3389/fgene.2024.1343411 . PMC   10894958 . PMID   38410153.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.